SGStephanie A. Goldstein

Stephanie A. Goldstein

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Stephanie A. Goldstein has a total of 80 co-authors. Here are the top co-authors by number of shared publications:

  • Albert Rocchini

    University of Michigan, C.S. Mott Children’s Hospital, Division of Pediatric Cardiology, Ann Arbor, MI, USA

    3 shared publications
  • Sunkyung Yu

    University of Michigan, C.S. Mott Children’s Hospital, Division of Pediatric Cardiology, Ann Arbor, MI, USA

    3 shared publications
  • Asaad G. Beshish

    Emory University School of Medicine

    2 shared publications
  • Joshua H. Wong

    Advocate Children’s Hospital

    2 shared publications
  • Mary K. Dahmer

    Department of Pediatrics, Division of Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA

    2 shared publications
  • Melissa Winder

    Division of Pediatric Critical Care Services, Primary Children's Hospital, 100 North Mario Capecchi Drive, Salt Lake City, UT 84112, USA

    2 shared publications

Latest Publications

  • Neutrophil Extracellular Traps and Acute Kidney Injury in Pediatric Patients Receiving Cardiopulmonary Bypass

    by Dana R. Tower, Sommer Glasgow, Camille P. Carter, Lawrence J. Cook, Christian C. Yost, David K. Bailly, Katja M. Gist, Stephanie A. Goldstein

    Objectives: To assess whether preoperative plasma neutrophil extracellular traps (NETs) are associated with acute kidney injury (AKI), CICU length of stay, duration of hospital length of stay, chylothorax, thrombus, necrotizing enterocolitis (NEC), and vasoactive-ventilator-renal (VVR) score in pediatric patients undergoing cardiopulmonary bypass (CPB). Design: Single-center, prospective observational cohort study. Setting: Tertiary academic pediatric hospital. Patients: A total of 118 pediatric patients (birth to < 18 yr) undergoing CPB between June 2022 and June 2024. Intervention: None. Measurements and Main Results: Preoperative plasma NET levels were quantified by measuring myeloperoxidase-DNA complex levels via enzyme-linked immunosorbent assay. AKI was defined using the Kidney Disease Improving Global Outcomes serum creatinine or urine output criteria. Creatinine was corrected for fluid balance on each postoperative day. AKI occurred in 31% of patients. Higher preoperative NET levels occurred more frequently among patients with postoperative AKI and lower Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery score 1–3 patients. A 1 sd increase in NET levels was also significantly associated with a 2.61-fold increase in odds of NEC in unadjusted logistic regression (OR, 2.61 [95% CI, 1.29–5.31]). No associations were observed with CICU length of stay, hospital length of stay, chylothorax, thrombosis, or VVR score. Conclusions: Elevated preoperative plasma NET levels may serve as a biomarker of early postoperative complications, including AKI and NEC, in pediatric CPB. Further studies are needed to validate these findings and explore targeted therapies.

  • Open Access

    Human milk and breastfeeding support in United States paediatric cardiac ICUs: a multicentre cohort and survey study

    by Kristin M. Elgersma, Brian F. Joy, Zuofu Huang, Monique R. Radman, Kimberly I. Mills, Jennifer E. Schramm, Joshua H. Wong, Meghan M. Chlebowski, Asaad G. Beshish, Raya Safa, et al.

    Human milk and direct breastfeeding are recommended for all infants, but rates are low in CHD with limited data on institutional lactation support. We aimed to describe lactation-supportive practices within US paediatric cardiac ICUs and to determine associations between these practices and human milk/breastfeeding outcomes. This retrospective cohort study and site survey included centres from Collaborative Research from the Pediatric Cardiac Intensive Care Society. Linear regression assessed associations between the total number of lactation-supportive practices and sites’ human milk and breastfeeding percentages, during the neonatal period and at discharge. Potentially strong clinical practices were identified through a phased analysis. Survey respondents represented 34 sites, with detailed data for 832 patients from 24 sites. Implementation of 22 lactation-supportive practices varied (median: 10; range: 2–20); smaller sites reported fewer practices ( p = 0.006). Common practices included in-room breast pumps (100%), feeding protocols (91%), and staff training (79%), while skin-to-skin protocols (41%) and automatic lactation orders (44%) were underutilised. While total practices did not correlate with outcomes, sites with high versus low implementation of “strongest” practices demonstrated generally better lactation outcomes, especially at discharge: 11.7% higher human milk volume (95% CI: 0.1%–23.3%); 8.2% higher breastfeeding rate (95% CI: −0.3%–16.6%). These strongest practices involved institutional formalisation of lactation support. Lactation-supportive practices varied among sites. Findings suggest formalisation of practices including a developmental care protocol, comprehensive parent education/support, and protocols recommending human milk/breastfeeding may improve lactation outcomes in critical CHD.

  • Open Access

    Analysis of Inflammatory Biomarkers in Patients With Chylothorax After Pediatric Cardiac Surgery

    by Stephanie A. Goldstein, Dana Tower, Camille P. Carter, Lawrence Cook, Thomas Martins, Sommer Glasgow, Robert A. Campbell, Frederik Denorme, Christian Con Yost

  • Pulmonary Atresia with Intact Ventricular Septum in the Neonate

    by Stephanie Goldstein, Melissa Winder, Dana Boucek


  • Cytokines in chest tube drainage after pediatric cardiac surgery – Is chylothorax the only phenotype?

    by Stephanie A. Goldstein, Melissa Winder, Camille Carter, J. Bair Diamond, Eric Bowles, Thomas B. Martins, Harry R. Hill, David K. Bailly


  • Open Access

    Analysis of inflammatory cytokines in the chest tube drainage of post-operative superior cavopulmonary connection patients

    by Stephanie A. Goldstein, Sunkyung Yu, Ray Lowery, Nadine L. N. Halligan, Mary K. Dahmer, Albert Rocchini

    Introduction: Prolonged pleural effusions are common post Fontan operation and are associated with morbidity. Fontan pleural effusions have elevated proinflammatory cytokines. Little is known about the chest tube drainage after a superior cavopulmonary connection. We examined the chest tube drainage and the inflammatory profiles in post-operative superior cavopulmonary connection patients.Methods: This prospective cohort study enrolled 25 patients undergoing superior cavopulmonary connection and 10 age-similar controls. Data are also compared to 25 previously published Fontan patients and their 15 age-similar controls. Chest tube samples were analysed with a 17-cytokine BioPlex Assay. Descriptive statistics and univariate comparisons were made between groups.Results: Duration of chest tube drainage was significantly shorter in superior cavopulmonary connection patients (median 4 days, [interquartile range 3–5 days]) versus Fontan patients (10 days, [7–11 days], p < 0.0001). Cytokine concentrations were higher on post-operative day 1 in superior cavopulmonary connection patients versus Fontan patients (all p ≤ 0.01), however levels were comparable to age-similar controls. While proinflammatory IL 8, MIP-1β, and TNF-α concentrations increased in chest tube drainage of Fontan patients from post-operative day 1 to last chest tube day (all p < 0.0001), there was no change in these biomarkers in superior cavopulmonary connection patients, their controls, or Fontan controls.Conclusions: Our study demonstrates that after superior cavopulmonary connection, proinflammatory cytokines in the chest tube drainage remain similar to biventricular controls of both age groups, unlike the significant rise over time observed in Fontan patients. Inflammation within the chest tube drainage is likely not innate to single ventricle patients.


  • Open Access

    Colchicine in post-operative Fontan patients

    by Stephanie A. Goldstein, Katherine Nolan, Kariann Marchetti, Janine K. Stoscup, Holli Clewis, Kathleen Jarvis, Nadine L.N. Halligan, Mary K. Dahmer, Kurt R. Schumacher, Albert Rocchini

    Background:Prolonged effusions post-Fontan procedure are associated with morbidity. Fontan patients have higher pro-inflammatory cytokines in chest tube drainage compared to controls. Colchicine, an anti-inflammatory medication, decreases effusions in adults after cardiac surgery. We hypothesised that patients post-Fontan treated with colchicine would have decreased pro-inflammatory cytokine levels and shorter duration of chest tube drainage.Methods:This pilot clinical trial enrolled nine patients (intention to treat); five completed the protocol (per protocol). Post-operative Fontan patients 20 months to 5 years receiving colchicine were compared to a previously published control cohort (n = 25). Per protocol patients received 0.6 mg colchicine daily starting post-operative day 2, ending 1 day after chest tube removal. Chest tube samples were taken on days 1–4, 7 and 10, or until removal and analysed with a 17-cytokine Bio-Plex Assay. Descriptive statistics and basic univariate comparisons were made.Results:There was no difference in duration of chest tube drainage or length of stay between intention to treat patients and controls. Per protocol patients had shorter duration of chest tube drainage compared to controls (6 days [interquartile range 4.7–7], versus 10 days [7–11], p = 0.007) and shorter length of stay (7 days [5.5–9] versus 9 days [9–13], p = 0.005). Pro-inflammatory cytokines trended lower in per protocol patients.Conclusions:In this pilot cohort, patients who completed the colchicine protocol post-Fontan procedure had shortened duration of chest tube drainage and length of stay. A decrease of pro-inflammatory cytokines may contribute to the mechanism of this change.ClinicalTrials.gov: Colchicine in Postoperative Fontan Patients (CPFP); NCT03575572; https://clinicaltrials.gov/ct2/show/NCT03575572.


  • Oral Aversion in Infants With Congenital Heart Disease: A Single-Center Retrospective Cohort Study*

    by Stephanie A. Goldstein, Kimberly J. Watkins, Ray E. Ba Lowery, Sunkyung Yu, Rachel M. Knight, Amy K. Drayton, Laura Ma Sayers, Michael Md Gaies

    OBJECTIVES: Neonates undergoing cardiac surgery are at risk for oral aversion (OA). OA is not well described outside of the index hospitalization and impacts patients and families. We evaluated the prevalence of OA at 1 year old after neonatal cardiopulmonary bypass (CPB) surgery. DESIGN: Retrospective cohort study. SETTING: Single quaternary care hospital. SUBJECTS: Our cohort included 157 neonates who underwent CPB surgery from 2014 to 2017 and had follow-up data available at 1 year old. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Three feeding experts reviewed the medical record to define children with OA; 30% of charts were evaluated in triplicate for validation. Neonates with and without OA were compared in univariate analysis, and risk factors for OA were explored in a limited multivariable analysis. OA was present at 1 year in 37 patients (23.6%) and other feeding difficulties were present in an additional 29 patients (18.5%). Thirty-eight patients (24.2%) had a feeding tube, including 12 (7.6%) with a gastrostomy tube. Factors associated with OA at 1 year included total ICU days, duration of mechanical ventilation, total number of nil per os days, and number of postoperative days (PODs) until oral feeding initiation (all p < 0.0001). Number of POD until oral feeding initiation remained independently associated with OA at 1 year in multivariable analysis (adjusted odds ratio, 1.08; 95% CI, 1.04–1.12; p < 0.0001). Infants with any oral intake at discharge had lower odds of OA at 1 year (0.21; 95% CI, 0.08–0.5; p = 0.0003). At hospital discharge, 132 patients (84.1%) were taking some oral feeds, and 128 patients (81.5%) received tube feeding. CONCLUSIONS: OA and other feeding difficulties are common at 1 year old in neonates undergoing CPB surgery. Delayed exposure to oral intake may be a modifiable risk factor for OA and efforts to improve early oral feeding could lead to better functional outcomes.


  • ANALYSIS OF INFLAMMATORY CYTOKINES IN THE CHEST TUBE DRAINAGE OF POSTOPERATIVE SUPERIOR CAVO-PULMONARY CONNECTION PATIENTS

    by Stephanie Goldstein, Sunkyung Yu, Ray Lowery, Nadine Halligan, Mary Dahmer, Albert Rocchini

  • Analysis of Inflammatory Cytokines in Postoperative Fontan Pleural Drainage

    by Stephanie A. Goldstein, Asaad G. Beshish, Lauren B. Bush, Ray E. Lowery, Joshua H. Wong, Kurt R. Schumacher, Nadine L. N. Halligan, Timothy T. Cornell, Albert P. Rocchini

    Prolonged pleural drainage is a common complication in patients after Fontan palliation and is associated with short- and long- term morbidities. Among many potential etiologies, prolonged drainage has an inflammatory component, but there are no descriptions of cytokines in Fontan pleural drainage to date. This study aimed to examine the inflammatory make-up of Fontan pleural drainage. This prospective age-range-matched cohort study recruited 25 patients undergoing Fontan procedure and 15 bi-ventricular patients undergoing cardiopulmonary bypass (CPB). Chest tube samples were taken on postoperative day (POD) 1–4, 7, and 10. Cytokines were measured using Bio-Plex Assays. Univariate comparisons were made in patient characteristics and cytokine levels. Median age was 3.7 y (IQR 2.8–3.9) for controls and 2.5 y (IQR 2.1–2.9) in Fontan patients (p = 0.02). Median drainage duration and daily volume was higher in Fontan patients (both p < 0.001). Inflammatory cytokines (IL-17A, IFN-y, MIP-1β, and TNF-α) were higher in Fontan patients than controls (all p < 0.02). There was an increase in pro-inflammatory cytokines (IL-8, MIP-1β, and TNF-α) from POD1 to the last chest tube day (LCD) in Fontan patients (all p < 0.0001) and a decrease in the anti-inflammatory cytokine IL-10 (p = 0.001). There was no difference in cytokine concentration from POD1 to LCD among controls. There was a significant association with the cytokine concentration of TNF-α on POD1 and duration of chest tube drainage (p < 0.05). Inflammatory cytokine levels in the pleural fluid of Fontan patients are higher compared to bi-ventricular controls and rise over time where controls do not. This suggests ongoing localized inflammation that is not a result of CPB alone and may be an important contributor to pleural drainage in patients after the Fontan procedure.